Pila Pharma Overview

  • Founded
  • 2014
Founded
  • Status
  • IPO Registration
  • Employees
  • 8
Employees
  • Latest Deal Type
  • IPO
  • (Announced)
  • Latest Deal Amount
  • $4.14M
Latest Deal Amount
  • Investors
  • 4

Pila Pharma General Information

Description

Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Västergatan 1
  • 211 21 Malmö
  • Sweden
+46 073-903 00 00

Pila Pharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pila Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 05-Jul-2021 $4.14M 00.000 000.00 Announced Clinical Trials - Phase 2
6. Angel (individual) 10-Mar-2021 00.000 00.000 Completed Clinical Trials - Phase 2
5. Grant 31-Jul-2019 000.00 00.000 Completed Clinical Trials - Phase 2
4. Early Stage VC 00.000 Completed Clinical Trials - Phase 2
3. Early Stage VC 09-May-2017 00.000 00.000 Completed Clinical Trials - Phase 2
2. Early Stage VC 01-Jun-2016 Completed Clinical Trials - Phase 2
1. Early Stage VC 01-Jan-2015 Completed Clinical Trials - Phase 2
To view Pila Pharma’s complete valuation and funding history, request access »

Pila Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel ty
Drug Discovery
Malmö, Sweden
8 As of 2021
00.000
00.00 0000-00-00
00000000 00.000

0000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000 000000000
Stockholm, Sweden
0 As of 0000
000.00
0000000000 0 000.00

00000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000000
South San Francisco, CA
00000 As of 0000
000.00
0000 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pila Pharma Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden 0 000.00 0000000000 0 000.00
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
0000000 Formerly VC-backed Boston, MA 0000 000000&0
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
You’re viewing 5 of 14 competitors. Get the full list »

Pila Pharma Executive Team (4)

Name Title Board Seat Contact Info
Dorte Gram Ph.D Founder, Chief Executive Officer & Board Member
Elna Åström Chief Financial Officer
Lars Rasmussen Chief Operating Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Pila Pharma Board Members (9)

Name Representing Role Since
Dorte Gram Ph.D Pila Pharma Founder, Chief Executive Officer & Board Member 000 0000
Fredrik Buch MD Self Chairman 000 0000
Lene Andersen Pila Pharma Board Member 000 0000
Tyge Korsgaard Self Board Member 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Pila Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pila Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Thomas Feldthus Angel (individual) Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Vimpu Intressenter Corporate Venture Capital Minority 000 0000 000000 0
Almi Invest Venture Capital Minority 000 0000 000000 0
To view Pila Pharma’s complete investors history, request access »

Pila Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 27-Sep-2016 00000 00000 00 00.000 Drug Discovery
Ario Pharma (TRPV1 antagonist asset) 30-Mar-2016 Corporate Asset Purchase Buildings and Property 00000 0000 00.0
To view Pila Pharma’s complete investments history, request access »